Singular Medical
Series C in 2025
Singular Medical is a technology company focused on the research and development of cardiac rhythm management (CRM) products. It specializes in designing and industrializing a comprehensive range of high-quality medical devices, including implantable cardioverter defibrillators, pacemakers, and implantable cardiac monitors. By creating a complete technical platform, Singular Medical offers solutions that encompass the entire patient journey, from initial detection of cardiac issues to ongoing follow-up care. The company's commitment to providing reliable and professional medical equipment aims to enhance the quality of care for patients with various cardiac conditions.
Guancheng Information Technology
Series A in 2024
Guancheng Information Technology specializes in developing and providing smart manufacturing solutions tailored for the medical device and high-technology electronics industries. Their primary offerings include Manufacturing Execution Systems (MES), equipment automation systems, and medical device intelligence solutions, aimed at enhancing automation and efficiency for industry users.
BabelFlex
Series B in 2024
BabelFlex is a developer of advanced sensors specializing in flexible electronics. The company provides innovative digital twinning services aimed at industrial clients, along with intelligent sensing solutions and data analytics. By leveraging state-of-the-art sensing technology, BabelFlex enables clients in the industrial and energy sectors to enhance operational efficiency and support the transition to a cleaner, more digitized world.
Rapid Flex
Seed Round in 2024
Rapid Flex focuses on programmable SOCs (PSoCs) and offers adaptable computer-aided design approaches for a seamless chip design experience. They also offer domain-specific embedded FPGA (eFPGA) solutions for a variety of industrial, consumer, communication, and automotive applications.
Qixin Micro Semiconductor
Series B in 2024
Suzhou Qixin Micro Semiconductor Co., Ltd. was established in October 2020. Based on the ARM Cortex M4, M7 and other series of architectures, it will build high-performance and high-reliability system-on-chips for different automotive application scenarios, and develop high-end smart car controller chips. Through the use of self-developed IP, unique multi-core lock-step technologies, and the unique Six Sigma analog circuit design process for automotive-standard chips, a full series of product families covering safety standards ISO26262 ASIL-B to ASIL-D have been designed. The company's products all meet the automotive regulations AEC-Q100, functional safety standard ISO26262 and various automotive regulations reliability tests, and can be widely used in the fields of body, automotive instrumentation, safety, power, battery management and other fields. The company is mainly engaged in the research and development and sales of high-end automotive controller chips. The goal is to fill the gap in the domestic new generation of intelligent networked automotive controller chips, and is committed to becoming a leading manufacturer in the field of automotive and industrial controllers in China.
Ouye Semiconductor
Series A in 2023
Ouyeel Semiconductor is a manufacturer of SoC chips. They offer smart car chips and solutions for automakers, enabling customers to reduce costs and time to develop new products and features.
Singular Medical
Series B in 2021
Singular Medical is a technology company focused on the research and development of cardiac rhythm management (CRM) products. It specializes in designing and industrializing a comprehensive range of high-quality medical devices, including implantable cardioverter defibrillators, pacemakers, and implantable cardiac monitors. By creating a complete technical platform, Singular Medical offers solutions that encompass the entire patient journey, from initial detection of cardiac issues to ongoing follow-up care. The company's commitment to providing reliable and professional medical equipment aims to enhance the quality of care for patients with various cardiac conditions.
Singular Medical
Series A in 2020
Singular Medical is a technology company focused on the research and development of cardiac rhythm management (CRM) products. It specializes in designing and industrializing a comprehensive range of high-quality medical devices, including implantable cardioverter defibrillators, pacemakers, and implantable cardiac monitors. By creating a complete technical platform, Singular Medical offers solutions that encompass the entire patient journey, from initial detection of cardiac issues to ongoing follow-up care. The company's commitment to providing reliable and professional medical equipment aims to enhance the quality of care for patients with various cardiac conditions.
Xie Zhu Technology
Series A in 2020
Xie Zhu Technology is a prominent service provider in China specializing in smart hotels and intelligent environments. The company focuses on integrating intelligent hardware and software to offer comprehensive solutions for hotels and apartments, facilitating the transformation into "future hotels." Xie Zhu Technology employs a unique approach that includes a platform, terminal, and application framework to enhance hotel operations significantly. It is recognized for its innovative 0-wired, non-stop strong electricity guest control installation solution, which allows for seamless integration of various device controls and customized scenarios. By creating diverse intelligent environments, Xie Zhu Technology enhances customer experience, leading to increased comfort, convenience, and personalization in hospitality services.